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Objectives. This study was designed to evaluate heart rate
variability (HRV) in patients with idiopathic dilated cardiomyop-
athy (IDC), to determine its correlation with hemodynamic vari-
ables and ventricular arrhythmias and to evaluate its prognostic
value in IDC.
Background. Previous studies have shown that HRV could
predict arrhythmic events in patients after infarction, but the
characteristics of HRV in IDC have not been fully established.
Methods. Time domain analysis of HRV on 24-h electrocardio-
graphic (ECG) recording was performed in 93 patients with IDC,
and results were compared with those in 63 control subjects.
Results. Patients with IDC, even those without congestive heart
failure, had significantly lower values for HRV than those of
control subjects. HRV was related to left ventricular shortening
fraction (R 5 0.5, p 5 0.0001) and to peak oxygen uptake (R 5
0.53, p 5 0.01). HRV was not different in patients with runs of
ventricular tachycardia or in patients with late potentials on the
signal-averaged ECG. During a mean follow-up period (6SD) of
49.5 6 35.6 months, patients with reduced HRV had an increased
risk of cardiac death or heart transplantation (p 5 0.006). On
multivariate analysis, cardiac events were predicted by increased
left ventricular end-diastolic diameter (p 5 0.0001), reduced
standard deviation of all normal to normal RR intervals (p 5
0.02) and increased pulmonary capillary wedge pressure (p 5
0.04).
Conclusions. Decreased HRV in patients with IDC is related to
left ventricular dysfunction and not to ventricular arrhythmias.
Analysis of HRV can identify patients with IDC who have an
increased risk of cardiac death or heart transplantation.
(J Am Coll Cardiol 1997;30:1009–14)
©1997 by the American College of Cardiology
Heart rate variability (HRV) gives information about the
influences of the autonomic nervous system. Several studies
(1–5) have shown correlations between decrease in HRV and
severity of several cardiac diseases, particularly in patients
recovering from acute myocardial infarction. Decreased HRV
has been related to the risk of ventricular arrhythmias and of
sudden death (4,5). We investigated HRV in patients with
idiopathic dilated cardiomyopathy (IDC) to determine the
correlation between HRV variables, hemodynamic data and
ventricular arrhythmias in this disease and to evaluate the
prognostic value of this method.
Methods
Patients. One hundred eleven patients with IDC according
to the definitions of the World Health Organization (6) were
continuously studied between February 1983 and May 1995.
Diagnosis was established by echocardiography, normal coro-
nary angiographic findings in all patients and radionuclide-
gated blood pool ventriculography. Patients aged .70 years or
with chronic renal failure, diabetes mellitus, atrial arrhythmias,
sinus node dysfunction, atrioventricular block or a permanent
pacemaker were excluded from analysis of HRV. Analysis of
HRV was possible in 93 patients (75 men, 18 women).
Twenty-seven patients (29%) had significant alcoholism (alco-
hol intake .80 g/day), seven (7.5%) had a history of paroxys-
mal atrial arrhythmia and six (6.6%) had moderate chronic
respiratory insufficiency. Forty-three patients (46.2%) were
receiving diuretic drugs, 42 (45.2%) digoxin, 29 (31.2%)
angiotensin-converting enzyme inhibitors, 14 (15.1%) nitrates
and 9 (9.7%) an antiarrhythmic agent (hydroxyquinidine in 5,
amiodarone in 3, cibenzoline in 1). No patients were receiving
beta adrenergic blocking agents either because they were
treated before 1990 or because they were seen at the time of
diagnosis of the disease. The control group included 63 healthy
subjects (33 men, 30 women) aged 20 to 70 years with no
cardiovascular symptoms, normal findings on a general exam-
ination, no medication that might affect autonomic nervous
activity, normal results on electrocardiography and echocardi-
ography and, in subjects aged .50 years, normal coronary
angiographic findings.
24-h ambulatory electrocardiographic (ECG) recording.
24-h ambulatory ECG recording was performed by two-
channel recorder. Antiarrhythmic agents were withdrawn $3
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days before the recording. All recordings were analyzed by
using the Oxford Medilog Excel 5-1 HRV system with manual
edition and correction of RR intervals and QRS complex.
Tapes were eligible if they had $22 h of analyzable data.
Ventricular arrhythmias were classified according to Lown
grade (7).
Time domain analysis of HRV included mean RR (mean
duration [ms] of all normal to normal RR [NN] intervals),
SDNN (standard deviation [ms] of all NN intervals), rmsSD
(square root of the sum of the squares of differences between
adjacent NN intervals [ms]) and day HR/night HR (ratio of day
mean heart rate [from 9 AM to 9 PM] to night mean heart rate
[from 0 AM to 6 AM]). SD estimates overall HRV, rmsSD
estimates short-term components of HRV, and day HR/night
HR estimates long-term components of HRV (1).
Signal-averaged ECG. Signal-averaged ECGs were ana-
lyzed with an Arrhythmia Research Technology model 101.
Cardiac beats were averaged until the noise level was ,0.5 mV.
The high pass filter was set at 25 Hz and the low pass filter at
250 Hz; the sampling frequency was 2,000 Hz. Analysis was
based on published standards of measurement (8). Results
were considered positive if the filtered QRS complex was
.120 ms, root-mean-square voltage was ,25 mV during the
last 40 ms of the filtered QRS complex and duration of the
filtered QRS complex was .35 ms after the voltage decreased
to ,40 mV. In cases of bundle branch block, results were
considered positive if the filtered QRS complex was .145 ms,
root-mean-square voltage was ,17 mV during the last 40 ms of
the filtered QRS complex and duration of the filtered QRS
complex was .45 ms after the voltage decreased to ,40 mV
(9).
Statistical analysis. Comparisons between groups were
made by using the Student t test and analysis of variance for
continuous variables. Linear regression analysis was carried
out to correlate quantitative variables. Survival curves were
estimated by the Kaplan-Meier method, and curves were
compared with the log rank test. Sudden death was defined as
death during sleep or instantaneous death within 1 h of the
onset of symptoms in a patient without evidence of the
presence of progressive heart failure (10). The effect of
hemodynamic variables, HRV, signal-averaged ECG and runs
of ventricular tachycardia (VT) was studied with univariate
analysis and multivariate regression analysis (proportional
hazards model). A forward stepwise model with a p value for
entry of 0.05 was used.
All values are given as mean value 6 SD. A p value ,0.05
was considered statistically significant. Statview 4.5 software
(Abacus Concepts) was used for statistical analysis.
Results
Characteristics of patients. The mean age of the patients
with IDC on hospital admission was 51.3 6 11 years (range 21
to 70). Seventy-five (80%) were men. The mean age of the
control group was 48.2 6 11.8 years and was not statistically
different from that of the patients with IDC. Clinical data and
results of 24-h ambulatory, signal-averaged and standard ECG,
radionuclide ventriculography and hemodynamic investiga-
tions are summarized in Table 1.
Comparison of HRV in patients with IDC and control
subjects. The mean HRV data for the 93 patients with IDC
and the control subjects are presented in Table 2. The two
groups differed significantly in heart rate and all HRV vari-
ables. Table 3 compares HRV variables in patients with IDC
with and without congestive heart failure with HRV variables
in the control group. HRV was lower in patients with IDC
without congestive heart failure than in the control group
Abbreviations and Acronyms
day HR/night HR 5 ratio of day mean heart rate to night mean
heart rate
ECG 5 electrocardiogram, electrocardiographic
HRV 5 heart rate variability
IDC 5 idiopathic dilated cardiomyopathy
LV 5 left ventricular
mean RR 5 mean duration of all normal to normal RR
intervals
NN interval 5 normal to normal RR interval
rmsSD 5 square root of the sum of the squares of
differences between adjacent normal to
normal RR intervals
SDNN 5 standard deviation of all normal to normal
RR intervals
VT 5 ventricular tachycardia
Table 1. Clinical Characteristics and Results of Echocardiography,
Hemodynamic Investigations, 24-h Ambulatory ECG Recording and
Signal-Averaged ECG in 93 Patients With IDC
Age (yr) 51.3 6 11
Gender (male/female) 75/18
NYHA class
I 33 (35.5%)
II 28 (30.1%)
III 23 (24.7%)
IV 9 (9.7%)
Duration of heart failure symptoms (mo) (n 5 60) 24.6 6 36
Systolic blood pressure (mm Hg) 121 6 15
Diastolic blood pressure (mm Hg) 75 6 9
Right bundle branch block 7 (7.5%)
Left bundle branch block 26 (28%)
LV end-diastolic diameter (mm) 66.3 6 8.9
LV end-systolic diameter (mm) 53.1 6 11.2
LV shortening fraction (%) 20.9 6 9
Pulmonary capillary wedge pressure (mm Hg) 12.5 6 8.6
Cardiac index (liters/min per m2) 3.01 6 0.77
LV ejection fraction 34.5 6 12%
Peak oxygen uptake (ml/kg per min) (n 5 31) 20.5 6 4.2
Holter ECG, Lown grade 4b 29 (31.2%)
LVP on signal-averaged ECG (n 5 85) 20 (23.5%)
Data presented are mean value 6 SD or number (%) of patients. ECG 5
electrocardiogram, electrocardiographic; IDC 5 idiopathic dilated cardiomyop-
athy; LV 5 left ventricular; LVP 5 late ventricular potentials; NYHA class 5
New York Heart Association function class.
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(whereas mean RR was not significantly different). Among
patients with IDC, those with congestive heart failure showed
a significantly lower mean RR, SDNN and day HR/night HR
ratio. HRV was significantly correlated with mean RR in the
control group for all variables, and in patients with IDC with
and without congestive heart failure for SDNN and day
HR/night HR (Table 4).
Correlation between HRV and hemodynamic variables,
ventricular arrhythmias and signal-averaged ECG in patients
with IDC. Correlations between measurements of HRV and
echocardiographic and hemodynamic variables and peak oxy-
gen uptake in patients with IDC are presented in Table 5.
HRV variables (especially SDNN and day HR/night HR ratio)
were related to left ventricular (LV) shortening fraction, LV
ejection fraction and peak oxygen uptake, but they were poorly
related to LV end-diastolic diameter, cardiac index and pres-
sure measurements on right heart catheterization. All HRV
variables correlated with LV shortening fraction. The highest
correlation coefficients were obtained with peak oxygen up-
take.
Patients with sustained or nonsustained VT on the 24-h
ambulatory ECG had no significant difference in HRV vari-
ables from those of patients without VT. Similarly HRV
variables did not differ between the patients with positive and
negative signal-averaged ECG findings (Table 6).
Analysis of mortality and cardiac events. The mean
follow-up period was 49.5 6 35.6 months. Fourteen patients
died during follow-up: eight with progressive congestive heart
failure, four with sudden death and two with noncardiac death
(cancer). Eight patients underwent heart transplantation and
one had cardiomyoplasty. Three patients had sustained VT:
The first had an implantable cardioverter-defibrillator, the
second underwent heart transplantation and the third had poor
therapy compliance and died suddenly. The survival curves of
patients with cardiac death (congestive heart failure or sudden
death), sudden death and cardiac events (cardiac death, heart
transplantation, cardiomyoplasty) are shown in Figure 1.
Survival curves of patients with cardiac events were com-
pared according to SDNN (Fig. 2). For this variable, it was
possible to determine a cutoff level that distinguished two
groups of patients with significantly different survival curves.
Such a cutoff level was not found for rmsSD and day HR/night
HR ratio. Univariate regression analysis showed that cardio-
vascular events were more frequent in patients with increased
LV end-diastolic diameter (p 5 0.0001), increased pulmonary
capillary wedge pressure (p 5 0.0001), decreased LV shorten-
ing fraction (p 5 0.0001), decreased LV ejection fraction (p 5
0.0001), decreased mean RR (p 5 0.014) and decreased
SDNN (p 5 0.018). Multivariate regression analysis demon-
strated that increased LV end-diastolic diameter (p 5 0.001),
depressed SDNN (p 5 0.02) and increased pulmonary capil-
lary wedge pressure (p 5 0.04) were the only predictors of
cardiac events.
Discussion
To our knowledge, a decrease in HRV in patients with IDC
without congestive heart failure has not previously been de-
scribed. In addition, our study is the first to correlate HRV
with both hemodynamic variables and ventricular arrhythmias
in a homogeneous group of patients with IDC. The longer
follow-up interval than that of previous studies allowed evalu-
ation of the prognostic value of HRV in IDC. The few studies
(11–16) that have focused on HRV in IDC all studied ,25
patients and examined the relation between HRV and LV
systolic function or hemodynamic status but rarely the relation
with ventricular arrhythmias or the signal-averaged ECG.
We emphasize that HRV was reduced in patients with IDC
Table 3. HRV Variables in Control Group and Patients With IDC
Without and With CHF
Control Group
(n 5 63)
IDC Without CHF
(NYHA class I)
(n 5 33)
IDC With CHF
(NYHA class II
to IV)
(n 5 60)
Age (yr) 48.2 6 11.8 52.6 6 9.8 50.6 6 11.7
Mean RR 783 6 101 790 6 120 701 6 102*†
SDNN 131 6 41 116 6 28* 90 6 42*†
rmsSD 41.7 6 18.8 28.4 6 13.5* 24 6 14.4*
Day HR/night HR 1.31 6 0.13 1.26 6 0.09* 1.18 6 0.1*†
*p , 0.05 versus control group. †p , 0.05 versus IDC without CHF. Data
presented are mean value 6 SD. CHF 5 congestive heart failure; other
abbreviations as in Tables 1 and 2.
Table 4. Correlation Between Mean RR and HRV Variables in
Control Group and Patients With IDC Without and With CHF
Control Group
(n 5 63)
IDC Without CHF
(NYHA class I)
(n 5 33)
IDC With CHF
(NYHA class II
to IV)
(n 5 60)
SDNN 0.43† 0.64† 0.6†
rmsSD 0.46† 0.59* 0.47*
Day HR/night HR 0.4* — —
*p , 0.01 versus control group. †p , 0.001. — 5 nonsignificant
correlation; other abbreviations as in Tables 1 to 3.
Table 2. HRV Variables in Control Group and Patients With IDC
Control Group
(n 5 63)
IDC
(n 5 93)
p
Value
Age (yr) 48.2 6 11.8 51.3 6 11 NS
Mean RR (ms) 783 6 101 732 6 116 *
SDNN 131 6 41 99 6 39 †
rmsSD (ms) 41.7 6 18.8 25.6 6 14.1 †
Day HR/night HR 1.31 6 0.13 1.21 6 0.1 †
*p , 0.001. †p , 0.0001. Data presented are mean value 6 SD. Day
HR/night HR 5 ratio of mean heart rate during the day (9 AM to 9 PM) to mean
heart rate during the night (0 AM to 6 AM); HRV 5 heart rate variability; IDC 5
idiopathic dilated cardiomyopathy; Mean RR 5 mean duration of all normal to
normal (NN) RR intervals; rmsSD 5 square root of the mean of the sum of the
squares of differences between adjacent NN intervals; SDNN 5 standard
deviation of all NN intervals.
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without congestive heart failure although mean RR was similar
to that of the control group. Some investigators have recom-
mended close attention to the relation between heart rate and
HRV: An increase in heart rate involves more limited varia-
tions in RR intervals and makes interpretation of HRV
difficult (17), as illustrated by the correlations of mean RR and
HRV variables shown in Table 4.
Using spectral analysis of HRV, Binkley et al. (11) demon-
strated a reduction in high frequencies and in the high
frequency/low frequency ratio in 10 patients with IDC and
congestive heart failure and suggested that parasympathetic
withdrawal and augmentation of sympathetic drive were both
components of autonomic imbalance in congestive heart fail-
ure. In fact, HRV analysis cannot really estimate sympathetic
or parasympathetic tone, only tone variations and modulation
of neural autonomic activity, and the changes of HRV vari-
ables induced by tone variations probably vary at different
stages of congestive heart failure (18,19). Congestive heart
failure is associated with an increase in sympathetic tone (with
increased plasma norepinephrine), whereas HRV variables are
reduced. Similarly, maximal physical exercise induces maximal
sympathetic stimulation that cannot be modulated by other
control mechanisms (20–22).
Correlations between a decrease in HRV and alteration of
systolic LV function in IDC are frequent but not constant
(12,14). The highest correlations in our study were obtained
with the recognized prognostic markers in congestive heart
failure: LV ejection fraction and peak oxygen uptake. IDC
could be one of the cardiac diseases with the most severe
decrease in HRV (13,15). For Mbaissouroum et al. (16), a
decrease in HRV could be the mechanism by which optimal
heart rate is set to optimize cardiac output.
There was no correlation in our study between HRV and
ventricular arrhythmias or signal-averaged ECG in patients
with IDC. In contrast, Vester et al. (15) found a weak (but not
significant) correlation between the presence of late ventricu-
lar potentials on signal-averaged ECG and a decrease in HRV.
Lown grade may have limits in patients with IDC, as perhaps
polymorphic premature ventricular contractions are more se-
vere than monomorphic nonsustained VT (23). Moreover, the
value of the signal-averaged ECG is probably limited by
frequent bundle branch block in patients with IDC, particularly
in those with severe LV dysfunction (8,9).
Overall and cardiac mortality rates at 5 years in our study
(19.1% and 15.3%) were similar to those of recent studies of
mortality in IDC (24). Mortality in IDC is closely related to left
ventricular function (24,25). There is a high incidence of
asymptomatic ventricular arrhythmias during 24-h ambulatory
ECG monitoring in patients with IDC, but the prognostic value
of these abnormalities remains controversial, even for sudden
death (26,27). The negative predictive value of the signal-
averaged ECG for prediction of sudden death is probably
good, but its positive predictive value remains low (27). Our
study shows that HRV is an independent prognostic marker in
IDC with more frequent cardiac events (cardiac death, heart
transplantation) in patients who have depressed SDNN (esti-
Table 5. Correlation Between HRV Variables and Hemodynamic Indexes in Patients With IDC
LVEDD LVSF PCWP CI LVEF Peak O2
Age — — — 0.25 — —
*
Mean RR 20.24 0.53 20.24 — 0.45 —
* § * §
SDNN — 0.5 20.27 — 20.36 0.53
§ † ‡ †
rmsSD — 0.26 — — — 0.39
* *
Day HR/Night HR — 0.35 0.26 0.27 0.33 0.46
† * * † †
*p , 0.05. †p , 0.01. ‡p , 0.001. §p , 0.0001. CI 5 cardiac index; LVEDD5 left ventricular end-diastolic diameter;
LVEF 5 left ventricular ejection fraction; LVSF 5 left ventricular shortening fraction; PCWP 5 pulmonary capillary
wedge pressure; Peak O2 5 peak oxygen uptake; — 5 nonsignificant correlation; other abbreviations as in Table 2.
Table 6. HRV Variables According to Presence or Absence of Severe Ventricular Arrhythmia (Lown grade 4b) or Late Ventricular Potentials
in Patients With IDC
Lown Grade on 24-h ECG LVP on Signal-Averaged ECG
Lown ,4b
(n 5 64)
Lown 4b
(n 5 29)
p
Value
Absent
(n 5 65)
Present
(n 5 20)
p
Value
Mean RR 733 6 111 730 6 129 NS 730 6 114 743 6 125 NS
SDNN 99.7 6 40.7 97.8 6 37.9 NS 100 6 38 91 6 36 NS
rmsSD 23.2 6 12.4 30.8 6 16.3 , 0.05 26.3 6 15 23.6 6 8.8 NS
Day HR/night HR 1.22 6 0.09 1.19 6 0.1 NS 1.21 6 0.12 1.21 6 0.09 NS
LVP 5 late ventricular potentials; other abbreviations as in Tables 1 and 2.
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mating overall HRV). Thus, analysis of HRV, in association
with hemodynamic variables, allows better identification of
patients at high risk of cardiac death. In our study, a decrease
in HRV did not identify patients who experienced sudden
death (which is only 29% of overall mortality), a finding in
agreement with other studies of HRV in congestive heart
failure (1,28). This finding differs from that of studies of HRV
after myocardial infarction in larger patient groups (4,5). It has
often been assumed (29) that sudden death in IDC is due to
ventricular tachyarrhythmias. However, the incidence of cere-
bral or pulmonary embolism, severe bradycardia or electrome-
chanical dissociation is probably underestimated in patients
with advanced heart failure, and these different mechanisms of
sudden death may explain differences between sudden death in
IDC and after acute myocardial infarction (30,31).
Conclusions. This study in 93 patients shows a reduction of
HRV in IDC, even in patients without congestive heart failure.
However, HRV becomes more depressed when hemodynamic
status deteriorates. HRV in IDC does not seem to be influ-
enced by the severity of ventricular arrhythmias. Our results
indicate that a reduction in SDNN is a prognostic marker of
cardiac events. The mechanisms of these abnormalities and the
effect on HRV of medical treatment to improve prognosis
remain to be demonstrated.
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